NCT00193687View on ClinicalTrials.gov

Bifeprunox in the Treatment of Schizophrenia

PHASE3CompletedINTERVENTIONAL
Enrollment

986

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

January 31, 2008

Study Completion Date

January 31, 2008

Conditions
Schizophrenia
Interventions
DRUG

bifeprunox

All Listed Sponsors
lead

Solvay Pharmaceuticals

INDUSTRY

NCT00193687 - Bifeprunox in the Treatment of Schizophrenia | Biotech Hunter | Biotech Hunter